Back to newsBofA Global Research raises Chemed price objective to $555 from $550CCHE•2026-10-28BofA Global Research raised its price objective for Chemed to $555 from $550.Related NewsNNiSource Q3 EPS $0.27NI•2026-10-28XXylem Inc: Citigroup cuts target price to $130 from $148XYL•2026-10-28BBoston Scientific Q3 adjusted EPS $0.73 vs. $0.72 estimateBSX•2026-10-28CCellectis plans Phase 1 trial of .HEAL-101 in China, expects initial data in second half of 2027CLLS•2026-10-28OOGE Energy Q3 revenue rises on warmer weatherOGE•2026-10-28
CHE•CHE•CHE•CHE•
